122 related articles for article (PubMed ID: 1533154)
1. Low-affinity binding sites for 1,4-dihydropyridines in skeletal muscle transverse tubule membranes revealed by changes in the fluorescence of felodipine.
Dunn SM; Bladen C
Biochemistry; 1992 Apr; 31(16):4039-45. PubMed ID: 1533154
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins.
Dunn SM; Bladen C
Biochemistry; 1991 Jun; 30(23):5716-21. PubMed ID: 1645998
[TBL] [Abstract][Full Text] [Related]
3. [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain.
Grassegger A; Striessnig J; Weiler M; Knaus HG; Glossmann H
Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):752-9. PubMed ID: 2561307
[TBL] [Abstract][Full Text] [Related]
4. Fluorescent probing with felodipine of the dihydropyridine receptor and its interaction with the ryanodine receptor calcium release channel.
Minarovic I; Mészáros LG
Biochem Biophys Res Commun; 1998 Mar; 244(2):519-24. PubMed ID: 9514900
[TBL] [Abstract][Full Text] [Related]
5. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
Murphy BJ; Tuana BS
Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
[TBL] [Abstract][Full Text] [Related]
6. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
Staudinger R; Knaus HG; Glossmann H
J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
[TBL] [Abstract][Full Text] [Related]
7. (+)-PN200-110 and ouabain binding sites in purified bovine adrenomedullary plasma membranes and chromaffin cells.
Castillo CJ; Fonteríz RI; López MG; Rosenheck K; García AG
J Neurochem; 1989 Nov; 53(5):1442-9. PubMed ID: 2529351
[TBL] [Abstract][Full Text] [Related]
8. Interaction of pinaverium (a quaternary ammonium compound) with 1,4-dihydropyridine binding sites in rat ileum smooth muscle.
Feron O; Wibo M; Christen MO; Godfraind T
Br J Pharmacol; 1992 Feb; 105(2):480-4. PubMed ID: 1313732
[TBL] [Abstract][Full Text] [Related]
9. A novel high affinity class of Ca2+ channel blockers.
Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
[TBL] [Abstract][Full Text] [Related]
10. Effects of diltiazem and verapamil on (+)-PN 200-110 binding kinetics in dog cardiac membranes.
Miwa K; Miyagi Y; Araie E; Sasayama S
Eur J Pharmacol; 1992 Apr; 214(2-3):127-32. PubMed ID: 1325351
[TBL] [Abstract][Full Text] [Related]
11. Binding Ca2+ to intracellular or to extracellular sites of dihydropyridine receptor of rabbit skeletal muscle discriminates between in vitro binding of Ca2+-channel agonist and antagonist.
Kanngiesser U; Pongs O
Eur J Biochem; 1989 May; 181(2):467-73. PubMed ID: 2540975
[TBL] [Abstract][Full Text] [Related]
12. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.
Reynolds IJ; Snowman AM; Snyder SH
J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067
[TBL] [Abstract][Full Text] [Related]
13. High-affinity binding of DTZ323, a novel derivative of diltiazem, to rabbit skeletal muscle L-type Ca++ channels.
Hagiwara M; Adachi-Akahane S; Nagao T
J Pharmacol Exp Ther; 1997 Apr; 281(1):173-9. PubMed ID: 9103495
[TBL] [Abstract][Full Text] [Related]
14. Dihydropyridine receptors in transverse tubules from normal and dystrophic chicken skeletal muscle.
Moro G; Saborido A; Delgado J; Molano F; Megias A
J Muscle Res Cell Motil; 1995 Oct; 16(5):529-42. PubMed ID: 8567940
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective inhibition of thromboxane-induced coronary vasoconstriction by 1,4-dihydropyridine calcium channel antagonists.
Eltze M; Boer R; Sanders KH; Boss H; Ulrich WR; Flockerzi D
Chirality; 1990; 2(4):233-40. PubMed ID: 1964575
[TBL] [Abstract][Full Text] [Related]
16. Calcium binding to extracellular sites of skeletal muscle calcium channels regulates dihydropyridine binding.
Ebata H; Mills JS; Nemcek K; Johnson JD
J Biol Chem; 1990 Jan; 265(1):177-82. PubMed ID: 2152918
[TBL] [Abstract][Full Text] [Related]
17. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
Nokin P; Clinet M; Beaufort P; Meysmans L; Laruel R; Chatelain P
J Pharmacol Exp Ther; 1990 Nov; 255(2):600-7. PubMed ID: 2147036
[TBL] [Abstract][Full Text] [Related]
18. Dihydropyridine binding to the L-type Ca2+ channel in rabbit heart sarcolemma and skeletal muscle transverse-tubules: role of disulfide, sulfhydryl and phosphate groups.
Murphy BJ; Washkurak AW; Tuana BS
Biochim Biophys Acta; 1990 May; 1052(2):333-9. PubMed ID: 2159349
[TBL] [Abstract][Full Text] [Related]
19. Relaxation of potassium chloride-induced contractions by amlodipine and its interaction with the 1,4-dihydropyridine-binding site in pig coronary artery.
Matlib MA
Am J Cardiol; 1989 Nov; 64(17):51I-57I. PubMed ID: 2530885
[TBL] [Abstract][Full Text] [Related]
20. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
Murphy BJ; Rogers CA; Sunahara RK; Lemaire S; Tuana BS
Mol Pharmacol; 1990 Feb; 37(2):173-81. PubMed ID: 2154669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
